New York, NY -- (ReleaseWire) -- 01/10/2014 -- Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) and DIRECTV (NASDAQ:DTV).
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) a biopharmaceutical company that engages in discovering, developing, and commercializing novel drugs that target G protein-coupled receptors in the therapeutic areas of cardiovascular, central nervous system, inflammatory, and metabolic diseases is currently up (+4.13%) on 4,829,621 shares traded after Arena Pharmaceuticals, Inc. announced that the company is scheduled to present a corporate overview at the 32nd Annual J.P. Morgan Healthcare Conference on Monday, January 13, 2014. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) is currently up (+58.27%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
DIRECTV (NASDAQ:DTV) a company that provides digital television entertainment in the United States and Latin America is currently up (+1.80%) on 2,305,026 shares traded after TheStreet Ratings rated Directv as a buy. DIRECTV (NASDAQ:DTV) is currently up (+50.91%) from its recent 52-week low which has prompted Growing Stock Report to add the stock to their NASDAQ Gainers Watch List.
Click Here to find out what other Investors are saying about DIRECTV (NASDAQ:DTV)
GrowingStockReport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals GrowingStockReport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.GrowingStockReport.com
GrowingStockReport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit GrowingStockReport.com website, for complete risks and disclosures.
Growing Stock Report